Mary Rozenman

Mary Rozenman is a Vice President at Longitude Capital. She focuses on investments in biotechnology. Prior to joining Longitude Capital in 2013, Dr. Rozenman was an Associate Principal at McKinsey & Company and a leader in the Healthcare and Corporate Finance practices. At McKinsey, she served clients in the biotechnology and medical technology industries on a variety of strategic and operational initiatives across commercial operations, research, clinical and corporate development. Dr. Rozenman also led the support of over $6 billion in healthcare transactions for McKinsey's leading private equity clients.